Moreover, addition of SHH at a later time point seems to favor MGE specification because when SHH was applied to β-catenin KO AD cells at days 4, 7, or 10, the latter yielded a better outcome of MGE progenitors (Figures S3H–S3M). Here, SHH is linked to Alzheimer disease.